IL-12 modulatory compounds

US7696202B2 · kind B2 · utility

Assignee

• Synta Pharmaceuticals Corp. · US

Inventors

• Lijun Sun · Harvard, US
• Elena Kostik · Arlington, US
• Teresa Przewloka · Tewksbury, US
• Howard P. Ng · El Sobrante, US
• Dinesh U. Chimmanamada · Arlington, US
• Zachary Demko · Los Altos, US

Key dates

• Filing date: Nov 10, 2005
• Grant date: Apr 13, 2010
• Expiry date: Aug 1, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to heterocyclic compounds, compositions including the compounds and methods of using and methods of making thereof. The compounds (and compositions) are useful, inter alia, in modulating IL-12 production and processes mediated by IL-12.